Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sintetica gmbh - ephedrinum hýdróklóríð - stungulyf, lausn - 50 mg/ml

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - ephedrini chloridum - stungulyf, lausn - 50 mg/ml

Evrópusambandið - íslenska - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - krabbamein, squamous cell - Æxlishemjandi lyf - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sonidegib tvífosfat - krabbamein, basalfrumur - Æxlishemjandi lyf - odomzo er ætlað til meðferðar hjá fullorðnum sjúklingum með staðbundið langt gengið grunnfrumukrabbamein (bcc) sem ekki er hægt að lækna með skurðaðgerð eða geislameðferð.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - rasagilinum tartrat - tafla - 1 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - linezolidum inn - innrennslislyf, lausn - 2 mg/ml

Evrópusambandið - íslenska - EMA (European Medicines Agency)

intervet international b.v. - svín circovirus tegund 2 (pcv2) orf2 undireiningar antigen r hyopneumoniae j álag óvirkt - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - svín (fyrir fitandi) - fyrir virka bólusetningar svín til að draga úr viraemia, veira hlaða í lungun og eitilfruma vefja, veira úthella af völdum svín circovirus tegund 2 (pcv2) sýkingu, og alvarleika lunga sár af völdum r hyopneumoniae sýkingu. til að draga úr tapi á daglegri þyngdaraukningu á klínískum tíma í ljósi sýkinga með mycoplasma hyopneumoniae og / eða pcv2 (eins og sést í rannsóknum á sviði).

Evrópusambandið - íslenska - EMA (European Medicines Agency)

zoetis belgium sa - live recombinant e2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus e2 gene (cp7_e2alf) - live viral vaccines, immunologicals for suidae - svín - fyrir virkan ónæmingu svína frá 7 vikna aldri til að koma í veg fyrir dauðsföll og draga úr sýkingu og sjúkdómum af völdum svínapestarveiru (csfv). onset of immunity: 14 days after vaccinationduration of immunity: at least 6 months after vaccinationfor active immunisation of breeding females to reduce transplacental infection caused by csfv. onset of immunity: 21 days after vaccinationduration of immunity has not been demonstrated.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

ptc therapeutics international limited - eladocagene exuparvovec - aminósýra efnaskipti, innfæddir villur - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - linezolidum inn - filmuhúðuð tafla - 600 mg